LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | JW-7-24-1 | 3.33 | uM | LJP6 | 1 | B20 | 72 | hr | 658 | 1312 | 3705 | 0.3540 | 0.3187 |
Hs 578T | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 658 | 1328 | 3807 | 0.3488 | 0.3194 |
Hs 578T | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 658 | 1562 | 3769 | 0.4144 | 0.4095 |
Hs 578T | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 658 | 266 | 3705 | 0.0718 | -0.3047 |
Hs 578T | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 658 | 323 | 3807 | 0.0848 | -0.2451 |
Hs 578T | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 658 | 253 | 3769 | 0.0671 | -0.3160 |
Hs 578T | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 658 | 725 | 3705 | 0.1956 | 0.0395 |
Hs 578T | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 658 | 709 | 3807 | 0.1862 | 0.0298 |
Hs 578T | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 658 | 650 | 3769 | 0.1724 | -0.0050 |
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 658 | 2443 | 3908 | 0.6251 | 0.6658 |
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 658 | 2630 | 3953 | 0.6652 | 0.7084 |
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 658 | 2490 | 3938 | 0.6322 | 0.6745 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 658 | 687 | 3705 | 0.1854 | 0.0173 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 658 | 672 | 3807 | 0.1765 | 0.0082 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 658 | 767 | 3769 | 0.2035 | 0.0626 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 658 | 1400 | 3908 | 0.3582 | 0.3413 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 658 | 1448 | 3953 | 0.3662 | 0.3564 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 658 | 1556 | 3938 | 0.3951 | 0.3956 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 658 | 593 | 3705 | 0.1600 | -0.0410 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 658 | 722 | 3807 | 0.1896 | 0.0372 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 658 | 689 | 3769 | 0.1828 | 0.0183 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 658 | 741 | 3908 | 0.1896 | 0.0472 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 658 | 920 | 3953 | 0.2327 | 0.1382 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 658 | 838 | 3938 | 0.2128 | 0.0981 |
Hs 578T | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 658 | 642 | 3705 | 0.1732 | -0.0099 |